Brewin Dolphin Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$32K Sell
967
-839
-46% -$35.6K ﹤0.01% 218
2022
Q1
$130K Sell
1,806
-18,435
-91% -$1.33M 0.01% 145
2021
Q4
$1.86M Sell
20,241
-1,380
-6% -$165K 0.2% 58
2021
Q3
$2.74M Buy
21,621
+3,470
+19% +$505K 0.31% 49
2021
Q2
$3.02M Buy
18,151
+8,034
+79% +$1.3M 0.37% 46
2021
Q1
$1.84M Buy
10,117
+9,467
+1,456% +$2.2M 0.28% 51
2020
Q4
$130K Hold
650
0.02% 123
2020
Q3
$143K Hold
650
0.03% 115
2020
Q2
$124K Buy
+650
New +$114K 0.03% 121
2020
Q1
Sell
-3,000
Closed -$251K 207
2019
Q4
$251K Buy
3,000
+1,000
+50% +$76.1K 0.12% 66
2019
Q3
$135K Hold
2,000
0.07% 86
2019
Q2
$133K Hold
2,000
0.07% 86
2019
Q1
$111K Hold
2,000
0.06% 90
2018
Q4
$99.1K Hold
2,000
0.06% 89
2018
Q3
$173K Buy
+2,000
New +$143K 0.09% 79

Other funds holding TDOC

Brewin Dolphin Wealth Management's TDOC Position: Q2 2022 in Review

Brewin Dolphin Wealth Management reduced its Teladoc Health (TDOC) stake by 46% in Q2 2022, selling an estimated $35.6K and leaving 967 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #218.

Brewin Dolphin Wealth Management first reported a position in TDOC in Q3 2018 and has held it in 15 quarters since. The position peaked at $3.02M in Q2 2021. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Brewin Dolphin Wealth Management held 967 shares of Teladoc Health worth $32K as of Q2 2022.
  • Brewin Dolphin Wealth Management sold 839 Teladoc Health shares in Q2 2022, an estimated $35.6K.
  • Teladoc Health made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #218 holding.
  • Brewin Dolphin Wealth Management first reported a position in Teladoc Health in Q3 2018 and has held it in 15 quarters since.
  • Brewin Dolphin Wealth Management's Teladoc Health position peaked at $3.02M in Q2 2021.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.